Free Trial

BrightSpring Health Services (BTSGU) Financials

BrightSpring Health Services logo
$60.30 -0.47 (-0.78%)
As of 04/17/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for BrightSpring Health Services

Annual Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-54 -155 -18
Consolidated Net Income / (Loss)
-54 -157 -21
Net Income / (Loss) Continuing Operations
-54 -157 -21
Total Pre-Tax Income
-46 -177 -35
Total Operating Income
188 147 206
Total Gross Profit
1,354 1,434 1,588
Total Revenue
7,721 8,826 11,266
Operating Revenue
7,721 8,826 11,266
Total Cost of Revenue
6,366 7,392 9,678
Operating Cost of Revenue
6,366 7,392 9,678
Total Operating Expenses
1,166 1,287 1,382
Selling, General & Admin Expense
1,126 1,287 1,382
Impairment Charge
41 0.00 0.00
Total Other Income / (Expense), net
-234 -325 -241
Interest Expense
234 325 241
Income Tax Expense
8.47 -21 -14
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.31 -2.23 -2.46
Basic Earnings per Share
($0.46) ($1.31) ($0.09)
Weighted Average Basic Shares Outstanding
117.84M 117.87M 193.00M
Diluted Earnings per Share
($0.46) ($1.31) ($0.09)
Weighted Average Diluted Shares Outstanding
117.84M 117.87M 193.00M
Weighted Average Basic & Diluted Shares Outstanding
- - 174.97M

Quarterly Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-21 3.99 -131 -6.54 -46 20 -8.23 16
Consolidated Net Income / (Loss)
-22 2.77 -130 -7.20 -46 19 -8.98 15
Net Income / (Loss) Continuing Operations
-22 2.77 -130 -7.20 -46 19 -8.98 15
Total Pre-Tax Income
-27 -0.07 -136 -15 -70 9.98 0.78 24
Total Operating Income
52 80 -52 68 8.07 62 57 79
Total Gross Profit
335 372 358 369 369 389 408 422
Total Revenue
2,028 2,167 2,257 2,375 2,577 2,730 2,907 3,053
Operating Revenue
2,028 2,167 2,257 2,375 2,577 2,730 2,907 3,053
Total Cost of Revenue
1,694 1,795 1,898 2,006 2,207 2,341 2,499 2,631
Operating Cost of Revenue
1,694 1,795 1,898 2,006 2,207 2,341 2,499 2,631
Total Operating Expenses
283 292 411 300 361 327 351 343
Selling, General & Admin Expense
283 292 411 300 361 327 351 343
Total Other Income / (Expense), net
-78 -80 -84 -83 -78 -52 -56 -55
Interest Expense
78 80 84 83 78 52 56 55
Income Tax Expense
-4.35 -2.83 -5.81 -7.59 -23 -9.47 9.76 8.78
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.89 -1.22 0.55 -0.66 -0.64 -0.48 -0.75 -0.60
Basic Earnings per Share
($0.18) $0.03 ($1.11) ($0.05) ($0.26) $0.10 ($0.04) $0.11
Weighted Average Basic Shares Outstanding
117.87M 117.88M 117.86M 117.87M 175.53M 197.52M 198.49M 193.00M
Diluted Earnings per Share
($0.18) $0.03 ($1.11) ($0.05) ($0.26) $0.10 ($0.04) $0.11
Weighted Average Diluted Shares Outstanding
117.87M 126.45M 117.86M 117.87M 175.53M 208.99M 198.49M 193.00M
Weighted Average Basic & Diluted Shares Outstanding
- - - 0.00 171.32M 171.46M 174.13M 174.97M

Annual Cash Flow Statements for BrightSpring Health Services

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
-33 -0.56 48
Net Cash From Operating Activities
-4.65 211 24
Net Cash From Continuing Operating Activities
-4.65 211 24
Net Income / (Loss) Continuing Operations
-54 -157 -21
Consolidated Net Income / (Loss)
-54 -157 -21
Depreciation Expense
204 202 204
Amortization Expense
20 21 12
Non-Cash Adjustments To Reconcile Net Income
78 38 124
Changes in Operating Assets and Liabilities, net
-252 107 -296
Net Cash From Investing Activities
45 -134 -140
Net Cash From Continuing Investing Activities
45 -134 -140
Purchase of Property, Plant & Equipment
-70 -74 -81
Acquisitions
-42 -63 -60
Divestitures
156 0.00 0.00
Other Investing Activities, net
2.14 2.15 0.47
Net Cash From Financing Activities
-74 -77 165
Net Cash From Continuing Financing Activities
-74 -77 165
Repayment of Debt
-41 -30 -3,443
Repurchase of Preferred Equity
0.00 -10 0.00
Repurchase of Common Equity
0.00 -0.65 -2.97
Payment of Dividends
-0.75 0.00 0.00
Issuance of Debt
-17 -24 2,968
Issuance of Common Equity
0.23 1.33 658
Other Financing Activities, net
-15 -13 -15
Cash Interest Paid
213 304 211
Cash Income Taxes Paid
29 37 25

Quarterly Cash Flow Statements for BrightSpring Health Services

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-2.45 0.08 0.39 1.43 45 -33 11 25
Net Cash From Operating Activities
40 -25 34 162 -79 -15 27 91
Net Cash From Continuing Operating Activities
40 -25 34 162 -79 -15 27 91
Net Income / (Loss) Continuing Operations
-22 2.77 -130 -7.20 -46 19 -8.98 15
Consolidated Net Income / (Loss)
-22 2.77 -130 -7.20 -46 19 -8.98 15
Depreciation Expense
50 50 51 51 49 50 51 55
Amortization Expense
5.20 5.31 5.18 5.23 4.45 2.49 2.54 2.63
Non-Cash Adjustments To Reconcile Net Income
10 10 9.62 7.49 46 21 27 30
Changes in Operating Assets and Liabilities, net
-3.39 -94 98 106 -132 -108 -44 -12
Net Cash From Investing Activities
-17 -45 -55 -17 -31 -58 -36 -16
Net Cash From Continuing Investing Activities
-17 -45 -55 -17 -31 -58 -36 -16
Purchase of Property, Plant & Equipment
-18 -21 -18 -17 -22 -24 -20 -15
Acquisitions
0.00 -25 -37 -0.55 -9.39 -34 -16 -0.04
Other Investing Activities, net
0.38 1.11 0.30 0.36 0.27 0.27 0.36 -0.43
Net Cash From Financing Activities
-25 71 21 -144 155 40 20 -50
Net Cash From Continuing Financing Activities
-25 71 21 -144 155 40 20 -50
Repayment of Debt
-22 6.76 -7.54 -7.58 -887 -2,527 -14 -16
Issuance of Debt
0.00 67 32 -122 389 2,571 41 -34
Issuance of Common Equity
0.09 0.06 0.45 0.74 656 0.40 0.13 1.00
Other Financing Activities, net
-2.89 -2.84 -2.90 -4.42 -3.08 -4.13 -6.22 -1.20
Cash Interest Paid
73 74 78 78 60 51 54 46
Cash Income Taxes Paid
3.73 23 9.08 1.86 11 13 0.62 0.64

Annual Balance Sheets for BrightSpring Health Services

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Total Assets
5,533 5,926
Total Current Assets
1,457 1,893
Cash & Equivalents
13 61
Accounts Receivable
882 1,029
Inventories, net
403 641
Prepaid Expenses
159 163
Plant, Property, & Equipment, net
246 250
Total Noncurrent Assets
3,830 3,783
Goodwill
2,608 2,672
Intangible Assets
881 811
Noncurrent Deferred & Refundable Income Taxes
0.00 5.58
Other Noncurrent Operating Assets
340 294
Total Liabilities & Shareholders' Equity
5,533 5,926
Total Liabilities
4,920 4,275
Total Current Liabilities
1,248 1,428
Short-Term Debt
32 49
Accounts Payable
642 941
Accrued Expenses
492 357
Other Current Liabilities
82 82
Total Noncurrent Liabilities
3,672 2,846
Long-Term Debt
3,332 2,562
Capital Lease Obligations
224 25
Noncurrent Deferred & Payable Income Tax Liabilities
24 0.00
Other Noncurrent Operating Liabilities
92 259
Redeemable Noncontrolling Interest
27 3.73
Total Equity & Noncontrolling Interests
585 1,648
Total Preferred & Common Equity
585 1,648
Preferred Stock
0.00 0.00
Total Common Equity
585 1,648
Common Stock
773 1,869
Retained Earnings
-200 -222
Accumulated Other Comprehensive Income / (Loss)
13 1.42
Noncontrolling Interest
0.67 0.00

Quarterly Balance Sheets for BrightSpring Health Services

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024
Total Assets
5,656 5,605 5,786
Total Current Assets
1,573 1,522 1,710
Cash & Equivalents
58 25 36
Accounts Receivable
991 985 1,026
Inventories, net
374 374 478
Prepaid Expenses
150 138 170
Plant, Property, & Equipment, net
246 246 249
Total Noncurrent Assets
3,837 3,838 3,828
Goodwill
2,609 2,626 2,673
Intangible Assets
856 851 842
Noncurrent Deferred & Refundable Income Taxes
11 22 6.68
Other Noncurrent Operating Assets
361 338 306
Total Liabilities & Shareholders' Equity
5,656 5,605 5,786
Total Liabilities
4,081 3,999 4,167
Total Current Liabilities
1,245 1,145 1,264
Short-Term Debt
49 49 49
Accounts Payable
656 669 784
Accrued Expenses
452 347 349
Other Current Liabilities
89 80 82
Total Noncurrent Liabilities
2,836 2,854 2,903
Long-Term Debt
2,515 2,564 2,609
Capital Lease Obligations
24 220 221
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 0.00 0.00
Other Noncurrent Operating Liabilities
297 71 74
Redeemable Noncontrolling Interest
6.28 5.94 4.13
Total Equity & Noncontrolling Interests
1,568 1,600 1,615
Total Preferred & Common Equity
1,567 1,600 1,615
Preferred Stock
0.00 0.00 0.00
Total Common Equity
1,567 1,600 1,615
Common Stock
1,790 1,807 1,850
Retained Earnings
-246 -226 -234
Accumulated Other Comprehensive Income / (Loss)
23 19 -0.71
Noncontrolling Interest
0.52 0.38 0.20

Annual Metrics and Ratios for BrightSpring Health Services

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
0.00% 14.32% 27.65%
EBITDA Growth
0.00% -10.14% 14.18%
EBIT Growth
0.00% -21.64% 40.22%
NOPAT Growth
0.00% -21.64% 40.22%
Net Income Growth
0.00% -189.26% 86.92%
EPS Growth
0.00% -184.78% 93.13%
Operating Cash Flow Growth
0.00% 4,630.05% -88.72%
Free Cash Flow Firm Growth
0.00% 0.00% 102.61%
Invested Capital Growth
0.00% 0.00% 0.91%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% -5.28%
Profitability Metrics
- - -
Gross Margin
17.54% 16.24% 14.10%
EBITDA Margin
5.34% 4.20% 3.75%
Operating Margin
2.43% 1.67% 1.83%
EBIT Margin
2.43% 1.67% 1.83%
Profit (Net Income) Margin
-0.70% -1.78% -0.18%
Tax Burden Percent
118.50% 88.40% 59.07%
Interest Burden Percent
-24.36% -120.54% -16.83%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 4.92% 3.43%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -9.62% -1.93%
Return on Net Nonoperating Assets (RNNOA)
0.00% -56.13% -5.25%
Return on Equity (ROE)
0.00% -51.21% -1.81%
Cash Return on Invested Capital (CROIC)
0.00% -195.08% 2.53%
Operating Return on Assets (OROA)
0.00% 2.66% 3.60%
Return on Assets (ROA)
0.00% -2.83% -0.36%
Return on Common Equity (ROCE)
0.00% -48.88% -1.79%
Return on Equity Simple (ROE_SIMPLE)
0.00% -26.82% -1.25%
Net Operating Profit after Tax (NOPAT)
131 103 144
NOPAT Margin
1.70% 1.17% 1.28%
Net Nonoperating Expense Percent (NNEP)
0.00% 14.54% 5.37%
Return On Investment Capital (ROIC_SIMPLE)
- 2.47% 3.37%
Cost of Revenue to Revenue
82.46% 83.76% 85.90%
SG&A Expenses to Revenue
14.58% 14.58% 12.27%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
15.11% 14.58% 12.27%
Earnings before Interest and Taxes (EBIT)
188 147 206
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
412 370 423
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 1.19 1.80
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00
Price to Revenue (P/Rev)
0.09 0.08 0.26
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.03 1.31
Enterprise Value to Revenue (EV/Rev)
0.00 0.49 0.49
Enterprise Value to EBITDA (EV/EBITDA)
0.00 11.60 13.11
Enterprise Value to EBIT (EV/EBIT)
0.00 29.19 26.86
Enterprise Value to NOPAT (EV/NOPAT)
0.00 41.70 38.37
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 20.38 233.17
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 52.08
Leverage & Solvency
- - -
Debt to Equity
0.00 5.86 1.60
Long-Term Debt to Equity
0.00 5.81 1.57
Financial Leverage
0.00 5.84 2.72
Leverage Ratio
0.00 9.03 5.06
Compound Leverage Factor
0.00 -10.89 -0.85
Debt to Total Capital
0.00% 85.42% 61.48%
Short-Term Debt to Total Capital
0.00% 0.77% 1.14%
Long-Term Debt to Total Capital
0.00% 84.65% 60.34%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.66% 0.09%
Common Equity to Total Capital
0.00% 13.92% 38.44%
Debt to EBITDA
0.00 9.69 6.23
Net Debt to EBITDA
0.00 9.65 6.09
Long-Term Debt to EBITDA
0.00 9.60 6.12
Debt to NOPAT
0.00 34.83 18.24
Net Debt to NOPAT
0.00 34.70 17.82
Long-Term Debt to NOPAT
0.00 34.52 17.91
Altman Z-Score
0.00 1.76 2.47
Noncontrolling Interest Sharing Ratio
0.00% 4.54% 1.39%
Liquidity Ratios
- - -
Current Ratio
0.00 1.17 1.33
Quick Ratio
0.00 0.72 0.76
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -4,085 106
Operating Cash Flow to CapEx
-6.64% 286.67% 29.38%
Free Cash Flow to Firm to Interest Expense
0.00 -12.58 0.44
Operating Cash Flow to Interest Expense
-0.02 0.65 0.10
Operating Cash Flow Less CapEx to Interest Expense
-0.32 0.42 -0.24
Efficiency Ratios
- - -
Asset Turnover
0.00 1.60 1.97
Accounts Receivable Turnover
0.00 10.01 11.80
Inventory Turnover
0.00 18.35 18.55
Fixed Asset Turnover
0.00 35.89 45.41
Accounts Payable Turnover
0.00 11.52 12.23
Days Sales Outstanding (DSO)
0.00 36.46 30.94
Days Inventory Outstanding (DIO)
0.00 19.89 19.67
Days Payable Outstanding (DPO)
0.00 31.68 29.85
Cash Conversion Cycle (CCC)
0.00 24.67 20.77
Capital & Investment Metrics
- - -
Invested Capital
0.00 4,188 4,226
Invested Capital Turnover
0.00 4.22 2.68
Increase / (Decrease) in Invested Capital
0.00 4,188 38
Enterprise Value (EV)
0.00 4,296 5,543
Market Capitalization
693 693 2,965
Book Value per Share
$0.00 $4.96 $9.46
Tangible Book Value per Share
$0.00 ($24.65) ($10.54)
Total Capital
0.00 4,201 4,287
Total Debt
0.00 3,588 2,636
Total Long-Term Debt
0.00 3,556 2,587
Net Debt
0.00 3,575 2,574
Capital Expenditures (CapEx)
70 74 81
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 227 452
Debt-free Net Working Capital (DFNWC)
0.00 240 513
Net Working Capital (NWC)
0.00 208 465
Net Nonoperating Expense (NNE)
186 260 165
Net Nonoperating Obligations (NNO)
0.00 3,575 2,574
Total Depreciation and Amortization (D&A)
224 223 217
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 2.58% 4.01%
Debt-free Net Working Capital to Revenue
0.00% 2.72% 4.56%
Net Working Capital to Revenue
0.00% 2.36% 4.12%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.09)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 193.00M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.09)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 193.00M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 174.97M
Normalized Net Operating Profit after Tax (NOPAT)
160 103 144
Normalized NOPAT Margin
2.07% 1.17% 1.28%
Pre Tax Income Margin
-0.59% -2.01% -0.31%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.80 0.45 0.86
NOPAT to Interest Expense
0.56 0.32 0.60
EBIT Less CapEx to Interest Expense
0.50 0.23 0.52
NOPAT Less CapEx to Interest Expense
0.26 0.09 0.26
Payout Ratios
- - -
Dividend Payout Ratio
-1.38% 0.00% 0.00%
Augmented Payout Ratio
-1.38% -0.41% -14.45%

Quarterly Metrics and Ratios for BrightSpring Health Services

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 27.03% 26.01% 28.82% 28.56%
EBITDA Growth
0.00% 0.00% 0.00% 0.00% -42.64% -14.92% 2,870.24% 9.69%
EBIT Growth
0.00% 0.00% 0.00% 0.00% -84.35% -21.61% 208.78% 15.81%
NOPAT Growth
0.00% 0.00% 0.00% 0.00% -84.35% 118.27% -1,691.56% 5.36%
Net Income Growth
0.00% 0.00% 0.00% 0.00% -108.23% 602.86% 93.10% 313.91%
EPS Growth
0.00% 0.00% 0.00% 0.00% -44.44% 233.33% 96.40% 320.00%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% -297.66% 39.59% -19.13% -44.20%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.91%
Revenue Q/Q Growth
0.00% 6.82% 4.14% 5.23% 0.00% 5.96% 6.47% 5.02%
EBITDA Q/Q Growth
0.00% 26.18% -97.26% 3,262.11% 0.00% 87.15% -4.34% 24.16%
EBIT Q/Q Growth
0.00% 54.43% -165.63% 230.64% 0.00% 673.70% -8.93% 39.08%
NOPAT Q/Q Growth
0.00% 54.43% -165.63% 230.64% 0.00% 2,054.16% -638.71% 107.68%
Net Income Q/Q Growth
0.00% 112.42% -4,804.41% 94.47% 0.00% 141.91% -146.20% 271.52%
EPS Q/Q Growth
0.00% 116.67% -3,800.00% 95.50% 0.00% 138.46% -140.00% 375.00%
Operating Cash Flow Q/Q Growth
0.00% -163.17% 233.67% 382.03% 0.00% 80.69% 278.96% 232.57%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -4.69% -19.24% 100.24%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 7.51% 1.10% -5.28%
Profitability Metrics
- - - - - - - -
Gross Margin
16.50% 17.17% 15.88% 15.53% 14.34% 14.25% 14.04% 13.82%
EBITDA Margin
5.28% 6.24% 0.16% 5.24% 2.38% 4.21% 3.78% 4.47%
Operating Margin
2.54% 3.67% -2.32% 2.87% 0.31% 2.29% 1.96% 2.59%
EBIT Margin
2.54% 3.67% -2.32% 2.87% 0.31% 2.29% 1.96% 2.59%
Profit (Net Income) Margin
-1.10% 0.13% -5.77% -0.30% -1.80% 0.71% -0.31% 0.50%
Tax Burden Percent
83.68% -4,067.65% 95.73% 48.68% 66.57% 194.90% -1,152.89% 63.69%
Interest Burden Percent
-51.64% -0.09% 260.14% -21.67% -863.75% 15.98% 1.37% 30.60%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% -94.90% 1,252.89% 36.31%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 4.24% 0.00% 0.00% 0.00% 4.42%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 2.70% 0.00% 0.00% 0.00% 3.28%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 15.78% 0.00% 0.00% 0.00% 8.91%
Return on Equity (ROE)
0.00% 0.00% 0.00% 20.02% 0.00% 0.00% 0.00% 13.33%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -97.54% 0.00% 0.00% 0.00% 2.53%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 4.59% 0.00% 0.00% 0.00% 5.09%
Return on Assets (ROA)
0.00% 0.00% 0.00% -0.48% 0.00% 0.00% 0.00% 0.99%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 19.11% 0.00% 0.00% 0.00% 13.14%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
36 56 -37 48 5.65 122 -655 50
NOPAT Margin
1.78% 2.57% -1.62% 2.01% 0.22% 4.46% -22.54% 1.65%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 1.54% 4.11% 7.28% -45.48% 1.14%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.14% - - - 1.18%
Cost of Revenue to Revenue
83.50% 82.83% 84.12% 84.47% 85.66% 85.75% 85.96% 86.18%
SG&A Expenses to Revenue
13.96% 13.50% 18.19% 12.65% 14.02% 11.96% 12.08% 11.23%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
13.96% 13.50% 18.19% 12.65% 14.02% 11.96% 12.08% 11.23%
Earnings before Interest and Taxes (EBIT)
52 80 -52 68 8.07 62 57 79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
107 135 3.70 124 61 115 110 137
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.19 0.37 1.22 1.56 1.80
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.26
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.03 0.76 1.08 1.20 1.31
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.49 0.00 0.00 0.00 0.49
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 11.60 0.00 0.00 0.00 13.11
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 29.19 0.00 0.00 0.00 26.86
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 41.70 0.00 0.00 0.00 38.37
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 20.38 0.00 0.00 0.00 233.17
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 52.08
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.00 0.00 5.86 1.64 1.76 1.78 1.60
Long-Term Debt to Equity
0.00 0.00 0.00 5.81 1.61 1.73 1.75 1.57
Financial Leverage
0.00 0.00 0.00 5.84 1.61 1.75 1.76 2.72
Leverage Ratio
0.00 0.00 0.00 9.03 3.59 3.49 3.57 5.06
Compound Leverage Factor
0.00 0.00 0.00 -1.96 -31.03 0.56 0.05 1.55
Debt to Total Capital
0.00% 0.00% 0.00% 85.42% 62.18% 63.81% 64.00% 61.48%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.77% 1.17% 1.10% 1.09% 1.14%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 84.65% 61.01% 62.72% 62.91% 60.34%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.66% 0.16% 0.14% 0.10% 0.09%
Common Equity to Total Capital
0.00% 0.00% 0.00% 13.92% 37.66% 36.04% 35.90% 38.44%
Debt to EBITDA
0.00 0.00 0.00 9.69 0.00 0.00 0.00 6.23
Net Debt to EBITDA
0.00 0.00 0.00 9.65 0.00 0.00 0.00 6.09
Long-Term Debt to EBITDA
0.00 0.00 0.00 9.60 0.00 0.00 0.00 6.12
Debt to NOPAT
0.00 0.00 0.00 34.83 0.00 0.00 0.00 18.24
Net Debt to NOPAT
0.00 0.00 0.00 34.70 0.00 0.00 0.00 17.82
Long-Term Debt to NOPAT
0.00 0.00 0.00 34.52 0.00 0.00 0.00 17.91
Altman Z-Score
0.00 0.00 0.00 1.72 0.10 0.35 0.43 2.40
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 4.54% 0.43% 0.39% 0.27% 1.39%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 0.00 0.00 1.17 1.26 1.33 1.35 1.33
Quick Ratio
0.00 0.00 0.00 0.72 0.84 0.88 0.84 0.76
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 0.00 -4,099 -4,291 -5,117 12
Operating Cash Flow to CapEx
223.56% -120.32% 188.23% 964.71% -361.47% -64.12% 135.94% 591.81%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -52.72 -81.83 -91.27 0.22
Operating Cash Flow to Interest Expense
0.51 -0.32 0.40 1.96 -1.01 -0.29 0.49 1.65
Operating Cash Flow Less CapEx to Interest Expense
0.28 -0.58 0.19 1.75 -1.29 -0.74 0.13 1.37
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.00 0.00 1.60 0.00 0.00 0.00 1.97
Accounts Receivable Turnover
0.00 0.00 0.00 10.01 0.00 0.00 0.00 11.80
Inventory Turnover
0.00 0.00 0.00 18.35 0.00 0.00 0.00 18.55
Fixed Asset Turnover
0.00 0.00 0.00 35.89 0.00 0.00 0.00 45.41
Accounts Payable Turnover
0.00 0.00 0.00 11.52 0.00 0.00 0.00 12.23
Days Sales Outstanding (DSO)
0.00 0.00 0.00 36.46 0.00 0.00 0.00 30.94
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 19.89 0.00 0.00 0.00 19.67
Days Payable Outstanding (DPO)
0.00 0.00 0.00 31.68 0.00 0.00 0.00 29.85
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 24.67 0.00 0.00 0.00 20.77
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 0.00 0.00 4,188 4,104 4,413 4,461 4,226
Invested Capital Turnover
0.00 0.00 0.00 2.11 0.00 0.00 0.00 2.68
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 0.00 4,104 4,413 4,461 38
Enterprise Value (EV)
0.00 0.00 0.00 4,296 3,117 4,759 5,364 5,543
Market Capitalization
693 693 693 693 580 1,946 2,517 2,965
Book Value per Share
$0.00 $0.00 $0.00 $4.96 $8.93 $9.34 $9.42 $9.46
Tangible Book Value per Share
$0.00 $0.00 $0.00 ($24.65) ($10.81) ($10.96) ($11.08) ($10.54)
Total Capital
0.00 0.00 0.00 4,201 4,163 4,438 4,497 4,287
Total Debt
0.00 0.00 0.00 3,588 2,588 2,832 2,878 2,636
Total Long-Term Debt
0.00 0.00 0.00 3,556 2,540 2,783 2,829 2,587
Net Debt
0.00 0.00 0.00 3,575 2,530 2,807 2,842 2,574
Capital Expenditures (CapEx)
18 21 18 17 22 24 20 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 227 318 400 459 452
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 240 376 426 495 513
Net Working Capital (NWC)
0.00 0.00 0.00 208 328 377 446 465
Net Nonoperating Expense (NNE)
58 53 94 55 52 102 -646 35
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 3,575 2,530 2,807 2,842 2,574
Total Depreciation and Amortization (D&A)
56 56 56 56 53 53 53 58
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 2.58% 0.00% 0.00% 0.00% 4.01%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 2.72% 0.00% 0.00% 0.00% 4.56%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 2.36% 0.00% 0.00% 0.00% 4.12%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 ($0.05) ($0.26) $0.10 ($0.04) $0.11
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 117.87M 175.53M 197.52M 198.49M 193.00M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($0.05) ($0.26) $0.10 ($0.04) $0.11
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 117.87M 175.53M 208.99M 198.49M 193.00M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 171.32M 171.46M 174.13M 174.97M
Normalized Net Operating Profit after Tax (NOPAT)
36 56 -37 48 5.65 44 40 50
Normalized NOPAT Margin
1.78% 2.57% -1.62% 2.01% 0.22% 1.60% 1.37% 1.65%
Pre Tax Income Margin
-1.31% 0.00% -6.02% -0.62% -2.70% 0.37% 0.03% 0.79%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
0.66 1.00 -0.62 0.82 0.10 1.19 1.01 1.44
NOPAT to Interest Expense
0.46 0.70 -0.44 0.58 0.07 2.32 -11.69 0.92
EBIT Less CapEx to Interest Expense
0.43 0.74 -0.84 0.62 -0.18 0.74 0.66 1.16
NOPAT Less CapEx to Interest Expense
0.23 0.44 -0.65 0.37 -0.21 1.87 -12.05 0.64
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -0.41% 0.00% 0.00% 0.00% -14.45%

Frequently Asked Questions About BrightSpring Health Services' Financials

When does BrightSpring Health Services's fiscal year end?

According to the most recent income statement we have on file, BrightSpring Health Services' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has BrightSpring Health Services' net income changed over the last 2 years?

BrightSpring Health Services' net income appears to be on a downward trend, with a most recent value of -$20.52 million in 2024, falling from -$54.22 million in 2022. The previous period was -$156.84 million in 2023.

What is BrightSpring Health Services's operating income?
BrightSpring Health Services's total operating income in 2024 was $206.37 million, based on the following breakdown:
  • Total Gross Profit: $1.59 billion
  • Total Operating Expenses: $1.38 billion
How has BrightSpring Health Services revenue changed over the last 2 years?

Over the last 2 years, BrightSpring Health Services' total revenue changed from $7.72 billion in 2022 to $11.27 billion in 2024, a change of 45.9%.

How much debt does BrightSpring Health Services have?

BrightSpring Health Services' total liabilities were at $4.27 billion at the end of 2024, a 13.1% decrease from 2023, and a 13.1% decrease since 2023.

How much cash does BrightSpring Health Services have?

In the past 1 years, BrightSpring Health Services' cash and equivalents has ranged from $13.07 million in 2023 to $61.25 million in 2024, and is currently $61.25 million as of their latest financial filing in 2024.

How has BrightSpring Health Services' book value per share changed over the last 2 years?

Over the last 2 years, BrightSpring Health Services' book value per share changed from 0.00 in 2022 to 9.46 in 2024, a change of 946.4%.



This page (NASDAQ:BTSGU) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners